Copy For Citation
DANE F., Ozgurdal K., YALÇIN Ş., BENEKLİ M., Aykan N. F., YÜCEL İ., ...More
BMJ OPEN, vol.10, no.3, 2020 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
10
Issue:
3
-
Publication Date:
2020
-
Doi Number:
10.1136/bmjopen-2018-027665
-
Journal Name:
BMJ OPEN
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
-
Bursa Uludag University Affiliated:
Yes
Abstract
Objectives Regorafenib improved overall survival in patients with metastatic colorectal cancer (mCRC) refractory to standard therapies in two randomised, phase III trials, but has not been evaluated in Turkey. REGARD evaluated the safety and efficacy of regorafenib in Turkish patients with treatment-refractory mCRC.